Literature DB >> 9360553

Substantial production of dopamine in the human gastrointestinal tract.

G Eisenhofer1, A Aneman, P Friberg, D Hooper, L Fåndriks, H Lonroth, B Hunyady, E Mezey.   

Abstract

Considerable urinary excretion of dopamine metabolites indicates that large amounts of dopamine are produced in unknown locations of the body. This study assessed the contribution of mesenteric organs (gastrointestinal tract, spleen, and pancreas) to the total body production of dopamine in humans and examined the presence of the rate-limiting enzyme for dopamine synthesis, tyrosine hydroxylase, in gastrointestinal tissues. Blood sampled from an artery and portal and hepatic veins in eight subjects and from arterial and renal venous sites in other subjects was analyzed for plasma concentrations of dopamine and its metabolites. The activity and distribution of tyrosine hydroxylase was also examined in tissue samples from the stomach and duodenum. Higher concentrations of dopamine and its metabolites in portal venous than arterial plasma indicated substantial production of dopamine by mesenteric organs (12.0 nmol/min) amounting to 42-46% of the renal removal of circulating dopamine metabolites. Tissue samples showed immunoreactive tyrosine hydroxylase in nonneuronal cell bodies and detectable levels of tyrosine hydroxylase in nonneuronal cell bodies and detectable levels of tyrosine hydroxylase enzyme activity. The results show that mesenteric organs produce close to half of the dopamine formed in the body, most of which is unlikely to be derived from sympathetic nerves but may reflect production in a novel nonneuronal dopaminergic system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9360553     DOI: 10.1210/jcem.82.11.4339

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  105 in total

1.  Decreased dopamine receptor expression and its second-messenger cAMP in malignant human colon tissue.

Authors:  S Basu; P S Dasgupta
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

Review 2.  Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma.

Authors:  Thamara E Osinga; Thera P Links; Robin P F Dullaart; Karel Pacak; Anouk N A van der Horst-Schrivers; Michiel N Kerstens; Ido P Kema
Journal:  FASEB J       Date:  2017-03-06       Impact factor: 5.191

3.  Bacteria-host communication: the language of hormones.

Authors:  Vanessa Sperandio; Alfredo G Torres; Bruce Jarvis; James P Nataro; James B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-07       Impact factor: 11.205

4.  Dopamine, by acting through its D2 receptor, inhibits insulin-like growth factor-I (IGF-I)-induced gastric cancer cell proliferation via up-regulation of Krüppel-like factor 4 through down-regulation of IGF-IR and AKT phosphorylation.

Authors:  Subhalakshmi Ganguly; Biswarup Basu; Saurav Shome; Tushar Jadhav; Sudipta Roy; Jahar Majumdar; Partha Sarathi Dasgupta; Sujit Basu
Journal:  Am J Pathol       Date:  2010-11-12       Impact factor: 4.307

Review 5.  Minireview: Dopaminergic regulation of insulin secretion from the pancreatic islet.

Authors:  Alessandro Ustione; David W Piston; Paul E Harris
Journal:  Mol Endocrinol       Date:  2013-06-06

6.  Neuronal source of plasma dopamine.

Authors:  David S Goldstein; Courtney Holmes
Journal:  Clin Chem       Date:  2008-09-18       Impact factor: 8.327

Review 7.  The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease.

Authors:  Phillip Mackie; Joe Lebowitz; Leila Saadatpour; Emily Nickoloff; Peter Gaskill; Habibeh Khoshbouei
Journal:  Brain Behav Immun       Date:  2018-03-15       Impact factor: 7.217

8.  A widely distributed metalloenzyme class enables gut microbial metabolism of host- and diet-derived catechols.

Authors:  Vayu Maini Rekdal; Paola Nol Bernadino; Michael U Luescher; Sina Kiamehr; Chip Le; Jordan E Bisanz; Peter J Turnbaugh; Elizabeth N Bess; Emily P Balskus
Journal:  Elife       Date:  2020-02-18       Impact factor: 8.140

9.  N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119.

Authors:  Zhi-Liang Chu; Chris Carroll; Ruoping Chen; Jean Alfonso; Veronica Gutierrez; Hongmei He; Annette Lucman; Charles Xing; Kristen Sebring; Jinyao Zhou; Brandee Wagner; David Unett; Robert M Jones; Dominic P Behan; James Leonard
Journal:  Mol Endocrinol       Date:  2009-11-09

10.  Differential effects of chemical sympathectomy on expression and activity of tyrosine hydroxylase and levels of catecholamines and DOPA in peripheral tissues of rats.

Authors:  M Kawamura; J P Schwartz; T Nomura; I J Kopin; D S Goldstein; T T Huynh; D R Hooper; J Harvey-White; G Eisenhofer
Journal:  Neurochem Res       Date:  1999-01       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.